Immunovaccine (IMV): Preparing to Cross the Valley of Death Harvard Case Solution & Analysis

The case describes the challenges faced by Immunovaccine (IMV), a small biotechnology company based in Halifax, Canada. The company has seen early success in the performance of their technology in the field of animal health and looking for ways to harness the potential of their technology more widely, especially in human health. The problems presented in the context of the development of relations between the pharmaceutical and biotechnology industries. The case describes the various issues facing the company around 2008, shortly after the new president and chief executive officer took over. He then provides detailed information on the development of strategy and execution in accordance with the new CEO. "Hide
Koretz by Ella Smith, Suhaib Riaz Source: Richard Ivey School of Business Foundation 18 pages. Publication Date: 13 October 2010. Prod. #: 910M72-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.